Year |
Citation |
Score |
2020 |
Zviran A, Schulman RC, Shah M, Hill STK, Deochand S, Khamnei CC, Maloney D, Patel K, Liao W, Widman AJ, Wong P, Callahan MK, Ha G, Reed S, Rotem D, ... ... Houck-Loomis B, et al. Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. Nature Medicine. PMID 32483360 DOI: 10.1038/S41591-020-0915-3 |
0.375 |
|
2020 |
Brannon AR, Jayakumaran G, Diosdado M, Hu Y, Razumova A, Meng F, Lebow E, Patel J, Johnson I, Srinivasan P, Hasan M, Dix J, Syed A, Houck-Loomis B, Li BT, et al. Abstract PR08: Validation and clinical implementation of MSK-ACCESS, an ultra-deep sequencing assay for noninvasive somatic mutation profiling Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Liqbiop20-Pr08 |
0.377 |
|
2019 |
Cocco E, Schram AM, Kulick A, Misale S, Won HH, Yaeger R, Razavi P, Ptashkin R, Hechtman JF, Toska E, Cownie J, Somwar R, Shifman S, Mattar M, Selçuklu SD, ... ... Houck-Loomis B, et al. Resistance to TRK inhibition mediated by convergent MAPK pathway activation. Nature Medicine. PMID 31406350 DOI: 10.1038/S41591-019-0542-Z |
0.31 |
|
2019 |
Varghese AM, Patel JAA, Janjigian YY, Meng F, Selcuklu SD, Zimel C, Hyman DM, Iyer G, Houck-Loomis B, Abou-Alfa GK, Berger MF, Lowery MA. Non-invasive detection of acquired resistance to FGFR inhibition in patients with cholangiocarcinoma harboring FGFR2 alterations. Journal of Clinical Oncology. 37: 4096-4096. DOI: 10.1200/Jco.2019.37.15_Suppl.4096 |
0.302 |
|
2019 |
Hasan MM, Patel J, Johnson I, Meng F, Tam GK, Jing X, Yang JL, Brannon AR, Gowtham J, Stephens DP, Diosdado M, Benayed R, Zehir A, Chen C, Weiser MR, ... ... Houck-Loomis B, et al. Abstract 1387: Tracking minimal residual disease in post-operative cell-free DNA using MSK-ACCESS Cancer Research. 79: 1387-1387. DOI: 10.1158/1538-7445.Am2019-1387 |
0.368 |
|
2018 |
Zviran A, Hill ST, Schulman R, Shah M, Deochand S, Ha G, Reed S, Rotem D, Gydush G, Rhoades J, Huang K, Liao W, Maloney D, Omans N, Malbari M, ... ... Houck-Loomis B, et al. Abstract 3247: Genome-wide cell-free DNA mutation integration for sensitive cancer detection Cancer Research. 78: 3247-3247. DOI: 10.1158/1538-7445.Am2018-3247 |
0.379 |
|
2017 |
Stoeckius M, Hafemeister C, Stephenson W, Houck-Loomis B, Chattopadhyay PK, Swerdlow H, Satija R, Smibert P. Simultaneous epitope and transcriptome measurement in single cells. Nature Methods. PMID 28759029 DOI: 10.1038/Nmeth.4380 |
0.333 |
|
2012 |
Green L, Houck-Loomis B, Yueh A, Goff SP. Large ribosomal protein 4 increases efficiency of viral recoding sequences. Journal of Virology. 86: 8949-58. PMID 22718819 DOI: 10.1128/Jvi.01053-12 |
0.49 |
|
2011 |
Houck-Loomis B, Durney MA, Salguero C, Shankar N, Nagle JM, Goff SP, D'Souza VM. An equilibrium-dependent retroviral mRNA switch regulates translational recoding. Nature. 480: 561-4. PMID 22121021 DOI: 10.1038/Nature10657 |
0.449 |
|
2007 |
Bouamr F, Houck-Loomis BR, De Los Santos M, Casaday RJ, Johnson MC, Goff SP. The C-terminal portion of the Hrs protein interacts with Tsg101 and interferes with human immunodeficiency virus type 1 Gag particle production. Journal of Virology. 81: 2909-22. PMID 17182674 DOI: 10.1128/Jvi.01413-06 |
0.433 |
|
Low-probability matches (unlikely to be authored by this person) |
2014 |
Nguyen UT, Bittova L, Müller MM, Fierz B, David Y, Houck-Loomis B, Feng V, Dann GP, Muir TW. Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries. Nature Methods. 11: 834-40. PMID 24997861 DOI: 10.1038/Nmeth.3022 |
0.286 |
|
2019 |
Patel J, Hasan M, Meng F, Jing X, Tam G, Johnson I, Zheng Y, Bandlamudi C, Stewart C, Won H, Hampton O, Schram A, Rosen E, Drilon A, Varghese A, ... ... Houck-Loomis B, et al. Abstract 2516: A bioinformatics framework for high-sensitivity detection and monitoring of oncogenic gene fusions in plasma cfDNA Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2516 |
0.261 |
|
2020 |
Yu HA, Schoenfeld AJ, Makhnin A, Kim R, Rizvi H, Tsui D, Falcon C, Houck-Loomis B, Meng F, Yang JL, Tobi Y, Heller G, Ahn L, Hayes SA, Young RJ, et al. Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic EGFR-Mutant Lung Cancers: A Phase 1/2 Single-Group Open-Label Trial. Jama Oncology. PMID 32463456 DOI: 10.1001/Jamaoncol.2020.1260 |
0.247 |
|
2013 |
Kim DH, Tang Z, Shimada M, Fierz B, Houck-Loomis B, Bar-Dagen M, Lee S, Lee SK, Muir TW, Roeder RG, Lee JW. Histone H3K27 trimethylation inhibits H3 binding and function of SET1-like H3K4 methyltransferase complexes. Molecular and Cellular Biology. 33: 4936-46. PMID 24126056 DOI: 10.1128/Mcb.00601-13 |
0.246 |
|
2021 |
Smyth LM, Reichel JB, Tang J, Patel JAA, Meng F, Selcuklu DS, Houck-Loomis B, You D, Samoila A, Schiavon G, Li BT, Razavi P, Piscuoglio S, Reis-Filho JS, Taylor BS, et al. Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study. Jco Precision Oncology. 5. PMID 34250397 DOI: 10.1200/PO.20.00184 |
0.246 |
|
2021 |
Tsui DWY, Cheng ML, Shady M, Yang JL, Stephens D, Won H, Srinivasan P, Huberman K, Meng F, Jing X, Patel J, Hasan M, Johnson I, Gedvilaite E, Houck-Loomis B, et al. Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients. Genome Medicine. 13: 96. PMID 34059130 DOI: 10.1186/s13073-021-00898-8 |
0.222 |
|
2021 |
Quintanal-Villalonga A, Taniguchi H, Zhan YA, Hasan MM, Chavan SS, Meng F, Uddin F, Allaj V, Manoj P, Shah NS, Chan JM, Ciampricotti M, Chow A, Offin M, Ray-Kirton J, ... ... Houck-Loomis B, et al. Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation. Journal of Hematology & Oncology. 14: 170. PMID 34656143 DOI: 10.1186/s13045-021-01186-z |
0.218 |
|
2018 |
Stoeckius M, Zheng S, Houck-Loomis B, Hao S, Yeung BZ, Mauck WM, Smibert P, Satija R. Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biology. 19: 224. PMID 30567574 DOI: 10.1186/S13059-018-1603-1 |
0.209 |
|
2020 |
Samoila A, Sosa J, Padilla J, Wutkowski M, Vanness K, Viale A, Berger M, Houck-Loomis B, Pessin M, Peerschke EI. Developing Quality Programs for Cell-Free DNA (cfDNA) Extraction from Peripheral Blood. The Journal of Applied Laboratory Medicine. 5: 788-797. PMID 32603443 DOI: 10.1093/jalm/jfaa050 |
0.172 |
|
2021 |
Varghese AM, Patel J, Janjigian YY, Meng F, Selcuklu SD, Iyer G, Houck-Loomis B, Harding JJ, O'Reilly EM, Abou-Alfa GK, Lowery MA, Berger MF. Noninvasive Detection of Polyclonal Acquired Resistance to FGFR Inhibition in Patients With Cholangiocarcinoma Harboring FGFR2 Alterations. Jco Precision Oncology. 5. PMID 34250419 DOI: 10.1200/PO.20.00178 |
0.171 |
|
2022 |
Strillacci A, Sansone P, Rajasekhar VK, Turkekul M, Boyko V, Meng F, Houck-Loomis B, Brown D, Berger MF, Hendrickson RC, Chang Q, de Stanchina E, Pareja F, Reis-Filho JS, Rajappachetty RS, et al. ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance. Npj Breast Cancer. 8: 96. PMID 35999225 DOI: 10.1038/s41523-022-00470-6 |
0.156 |
|
Hide low-probability matches. |